<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: FDA Advisory on Gadolinium contrast agents</title>
	<atom:link href="http://www.refscan.info/2007/01/28/fda-advisory-on-gadolinium-contrast-agents/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.refscan.info/2007/01/28/fda-advisory-on-gadolinium-contrast-agents/</link>
	<description>Magnetic Resonance Imaging news, information, and journal club, with minimal spin.</description>
	<pubDate>Wed, 19 Nov 2008 22:30:49 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.3</generator>
		<item>
		<title>By: Unsafe Drugs</title>
		<link>http://www.refscan.info/2007/01/28/fda-advisory-on-gadolinium-contrast-agents/#comment-474</link>
		<dc:creator>Unsafe Drugs</dc:creator>
		<pubDate>Wed, 06 Jun 2007 18:13:47 +0000</pubDate>
		<guid isPermaLink="false">http://www.refscan.info/2007/01/28/fda-advisory-on-gadolinium-contrast-agents/#comment-474</guid>
		<description>&lt;strong&gt;Mother Sues Bayer Over Death of Son...&lt;/strong&gt;

Beverly Rockwell plans to seek compensatory and punitive damages on behalf of her son, Trevor A. Drake, who died after an injection of Magnevist. Rockwell claims that Magnevist, made by Bayer, was responsible for her son's death. The lawsuit alleges.....</description>
		<content:encoded><![CDATA[<p><strong>Mother Sues Bayer Over Death of Son&#8230;</strong></p>
<p>Beverly Rockwell plans to seek compensatory and punitive damages on behalf of her son, Trevor A. Drake, who died after an injection of Magnevist. Rockwell claims that Magnevist, made by Bayer, was responsible for her son&#8217;s death. The lawsuit alleges&#8230;..</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: nanotech contrast agents at Reference Scan</title>
		<link>http://www.refscan.info/2007/01/28/fda-advisory-on-gadolinium-contrast-agents/#comment-6</link>
		<dc:creator>nanotech contrast agents at Reference Scan</dc:creator>
		<pubDate>Mon, 05 Feb 2007 14:24:16 +0000</pubDate>
		<guid isPermaLink="false">http://www.refscan.info/2007/01/28/fda-advisory-on-gadolinium-contrast-agents/#comment-6</guid>
		<description>[...] in MR simply gives us another lever with which we can manipulate the system. To that end, the Nephrogenic Systemic Fibrosis (NSF) advisory from the FDA is of grave concern. For the vast majority of patients, gadolinium-based contrast agents are [...]</description>
		<content:encoded><![CDATA[<p>[...] in MR simply gives us another lever with which we can manipulate the system. To that end, the Nephrogenic Systemic Fibrosis (NSF) advisory from the FDA is of grave concern. For the vast majority of patients, gadolinium-based contrast agents are [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
